Literature DB >> 30826256

Mobile health applications enhance weight loss efficacy following bariatric surgery.

Christopher W Mangieri1, Rebekah J Johnson2, Lori B Sweeney3, Yong U Choi4, Joseph C Wood5.   

Abstract

INTRODUCTION: With the epidemic of obesity numerous mobile health (mHealth) applications have been designed with the goal of facilitating weight loss. This technology has the potential to focus behavioral modification in a manner that's effective for weight loss. We examined the use of this mHealth technology in our bariatric surgery population to evaluate effects on weight loss following surgery.
METHODS: Single institution prospective randomized control trial performed at an academic center. 56 patients who recently underwent a laparoscopic sleeve gastrectomy (LSG) were enrolled into a control group with standard post-operative monitoring and a mHealth application group provided with iPad© minis with the MyFitnessPal© mHealth application. Participants were followed for 24 months. The primary outcomes were effect on weight loss as determined by excess body weight loss (%EWL) and excess BMI loss (%EBL).
RESULTS: Statistically significant differences in weight loss outcomes between the groups were present throughout the duration of the study. At 12 months, %EWL was 74.41% (control) vs 81.41% (mHealth) p value 0.047 and at 24 months, it was 59.10% (control) vs 71.47% (mHealth) p value 0.0078. %EBL findings at 12 months was 28.02% (control) vs 32.15% (mHealth) p value 0.0007 and at 24 months, it was 25.39% (control) vs 27.87% (mHealth) p value 0.048.
CONCLUSION: Our results demonstrate mHealth applications are a useful adjunct to improve and maintain weight loss following bariatric surgery. We suggest mHealth applications should be utilized following bariatric surgery for improved outcomes.
Copyright © 2019 Asia Oceania Association for the Study of Obesity. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bariatric surgery; Improved weight loss; Mobile health applications; mHealth

Mesh:

Year:  2019        PMID: 30826256     DOI: 10.1016/j.orcp.2019.01.004

Source DB:  PubMed          Journal:  Obes Res Clin Pract        ISSN: 1871-403X            Impact factor:   2.288


  6 in total

1.  An Initial Test of the Efficacy of a Digital Health Intervention for Bariatric Surgery Candidates.

Authors:  Robyn Sysko; Andreas Michaelides; Kayla Costello; Daniel M Herron; Tom Hildebrandt
Journal:  Obes Surg       Date:  2022-09-08       Impact factor: 3.479

Review 2.  Application and effectiveness of eHealth strategies for metabolic and bariatric surgery patients: A systematic review.

Authors:  Sarah E Messiah; Paul M Sacher; Joshua Yudkin; Ashley Ofori; Faisal G Qureshi; Benjamin Schneider; Deanna M Hoelscher; Nestor de la Cruz-Muñoz; Sarah E Barlow
Journal:  Digit Health       Date:  2020-01-07

3.  Lifestyle counselling by persuasive information and communications technology reduces prevalence of metabolic syndrome in a dose-response manner: a randomized clinical trial (PrevMetSyn).

Authors:  Young-Gyun Seo; Tuire Salonurmi; Terhi Jokelainen; Pasi Karppinen; Anna-Maria Teeriniemi; Junhee Han; Kyung Hee Park; Harri Oinas-Kukkonen; Markku J Savolainen
Journal:  Ann Med       Date:  2020-09       Impact factor: 4.709

Review 4.  Nutrition-Related Mobile Apps in the French App Stores: Assessment of Functionality and Quality.

Authors:  Prescilla Martinon; Ina Saliasi; Laurie Fraticelli; Florence Carrouel; Denis Bourgeois; Colette Smentek; Claude Dussart
Journal:  JMIR Mhealth Uhealth       Date:  2022-03-14       Impact factor: 4.947

5.  The Effects of e-Mobile Training and Consultancy Services on Bariatric Surgery Patients: A Randomized Clinical Trial.

Authors:  Sevgi Deniz Doğan; Sevban Arslan
Journal:  Obes Surg       Date:  2022-09-01       Impact factor: 3.479

6.  iColon, a patient-focused mobile application for perioperative care in colorectal surgery: an observational, real-world study protocol.

Authors:  Elisa Bertocchi; Giuliano Barugola; Irene Gentile; Teresa Zuppini; Massimo Zamperini; Massimo Guerriero; Renato Avesani; Silvia Bonadiman; Chiara Anselmi; Giacomo Ruffo
Journal:  BMJ Open       Date:  2021-11-02       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.